In his Invest with an Edge, he explains, "One bank in particular is exerting itself again as a dominant player: Wells Fargo & Company (NYSE: WFC)." Here's his review.

"The painful declines in bank stocks appear to have stopped for now, as bank stocks have exploded off the March lows. As we've observed, financials have 'friends in high places.'

"Banks in general are showing promise as credit becomes easier. There's still a long way to go for complete recovery, but the trend is pointing up.

Continue reading Wells Fargo (WFC): 'Ride the financial wave'

Wells Fargo (WFC): 'Ride the financial wave' originally appeared on BloggingStocks on Fri, 09 Oct 2009 15:20:00 EST. Please see our terms for use of feeds.

In his Invest with an Edge advisory service, the growth stock advisor looks to Celgene Corporation (NASDAQ: CELG), a player in developing cancer treatments. Here's his review.

"This sometimes-perilous market niche can make or break a portfolio depending on several factors: drug pipeline, continued investment, market factors, and government approvals.

"However, despite the risks, there are times when we believe that individual biotech stocks make sense -- such as our latest recommendation for Celgene.

Continue reading Celgene (CELG): Cancer progress boosts biotech

Celgene (CELG): Cancer progress boosts biotech originally appeared on BloggingStocks on Wed, 19 Aug 2009 14:00:00 EST. Please see our terms for use of feeds.

"Certain commodities are getting hot again; both copper and gold have the wind at their backs in this market, while uranium has also caught our attention," says Brandon Clay.

In his Invest with an Edge, he explains, "One such company that should gain from a spike in gold, uranium, and copper is Vancouver-based Fronteer Development Group (NYSE: FRG).

"Uranium is a perennially despised substance with a back story in catastrophe, espionage, protests, and nuclear fallout. But this sometimes-sordid history may prove too weak an objection for the outstanding potential in uranium.

Continue reading Fronteer (FRG): Copper, gold & uranium

Fronteer (FRG): Copper, gold & uranium originally appeared on BloggingStocks on Wed, 03 Jun 2009 13:40:00 EST. Please see our terms for use of feeds.

"Who will gain from the ongoing troubles at the Big-3 automakers in the US?" asks growth stock specialist Brandon Clay.

In his Invest with an Edge, the growth stock advisors takes a look at Tata Motors Ltd. (NYSE: TTM) which is expected to launch the world's cheapest car. Here's the advisor's review.

"Tata Motors is part of one of the largest manufacturing entities on the planet, will soon release the world's cheapest automobile in the United States.

"Debuting at $2000, the Tata Nano is set for a July 2009 delivery. Tata already has 1 million reservations for their mini-car. If they could deliver, it would easily become the best-selling car this year.

Continue reading Tata Motors (TTM): Mini-car opportunity

Tata Motors (TTM): Mini-car opportunity originally appeared on BloggingStocks on Thu, 14 May 2009 10:30:00 EST. Please see our terms for use of feeds.

Two leading growth stock expert, Brandon Clay, editor of Invest with an Edge, and Alexander Green, editor of The Oxford Club, turn to automated blood testing equipment maker Immucor (NASDAQ: BLUD) as a recession-resistant buy.

Clay suggest, "A good bet is to go with the strongest stock in that particular sector at the time of your pickThat way, the company you select at least has the momentum of the sector backing it. Typically the medical industry performs better than the overall market in a downturn. This recession has been no different.

"As we dug deeper into health care, one company surfaced that was worth our attention. Immucor is a blood testing equipment manufacturer specializing in pre-transfusion diagnostics.

"Established in 1982, they brought their first patent to market four years later. Since then they've become a leader in blood diagnostics and blood bank technology.

Continue reading Immucor (BLUD): Two experts bank on blood bank buy

Immucor (BLUD): Two experts bank on blood bank buy originally appeared on BloggingStocks on Mon, 23 Feb 2009 14:00:00 EST. Please see our terms for use of feeds.

"Although equities tend to have attractive multi-year growth rates, there is always risk," caution Ron Rowland and Brandon Clay.

In their Invest with an Edge, they explain, "That's why investors have been taking a second look at bonds, specifically municipal bonds." Here's an ETF offering exposure to the muni bond sector.

"Affectionately called 'munis', municipal bonds have enjoyed a resurgence among retail investors, who are buying munis for three reasons:

1) Munis Have High Yield & No Taxes in Difficult Markets

"Municipal bonds are unique investment vehicles. They offer yields, but the interest is not taxed by the IRS. That way, the 'effective' yield for the muni is often higher than on taxable bonds. Moreover, as prices for munis have been falling, yields have been rising.

2) Munis Are Relatively Safe Investments

"When you're buying a muni bond, you're actually loaning to a state/local government or their agencies. Although cities can go bankrupt - thus preventing you from receiving back your initial investment - at least we can vote on governors and mayors.

"As a result, munis are a safer investment than many corporate bonds. Munis are one way for investors to find safety in this market.

Continue reading For stable income consider muni bond ETF

For stable income consider muni bond ETF originally appeared on BloggingStocks on Thu, 13 Nov 2008 17:40:00 EST. Please see our terms for use of feeds.

In the latest annual survey in Barron's of professional investors Johnson and Johnson (NYSE: JNJ) was rated the world's most respected company," reports Ron Rowland and Brandon Clay.

In Invest With an Edge, the advisors look at the 123-company, which he selects as " a solid healthcare pick in a strong long-term uptrend."

"This New Jersey-based company has come a long way since corner drugstores sold their baby powder. Beginning as a pioneer in sterile medical supplies, they expanded into pharmaceuticals and related consumer products.

"Over the years, they've released ubiquitous brands such as Band-Aid, Rogaine, Listerine, Tylenol, even Splenda. Johnson and Johnson has become a household name.

"However, Johnson & Johnson is a healthcare company with deeper product lines; it is ivided into three segments: Consumer, Pharmaceutical and Medical Devices & Diagnostics.

Continue reading Johnson & Johnson (JNJ): The most 'respected' company

Johnson & Johnson (JNJ): The most 'respected' company originally appeared on BloggingStocks on Wed, 24 Sep 2008 12:15:00 EST. Please see our terms for use of feeds.